Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Health-Related Quality of Life Among Postpartum Women in Jordan: A Cross-Sectional Study.

Healthcare (Basel, Switzerland)·2026
Same author

Deep Learning Based Computer-Aided Detection of Prostate Cancer Metastases in Bone Scintigraphy: An Experimental Analysis.

Journal of imaging·2026
Same author

Evaluating the Severity of COVID-19 Infection in Patients With Obstructive Sleep Apnea in Jordan.

Pulmonary medicine·2025
Same author

An Embedded Mixed-Methods Study with a Dominant Quantitative Strand: The Knowledge of Jordanian Mothers About Risk Factors for Childhood Hearing Loss.

Audiology research·2025
Same author

Young Women's Perspectives About Vaping: A Cross Sectional Study from Jordan.

Journal of community health·2025
Same author

The assessment of public perception towards chronic kidney disease in Jordan: a cross-sectional study.

Annals of medicine·2024

Related Experiment Video

Updated: Jul 16, 2026

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
09:16

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

Predicting Chronic Kidney Disease from Biomarkers: An Explainable Machine Learning Approach.

Abass Al-Momany1, Omar Almomani2, Ensaf Y Almomani3

  • 1Department of Medical Laboratory Sciences, The University of Jordan, Queen Rania St, Amman 11942, Jordan.

Diagnostics (Basel, Switzerland)
|July 15, 2026
PubMed
Summary

A new machine learning framework accurately detects chronic kidney disease (CKD) early. Gradient boosting models, particularly LightGBM, show high performance, enabling reliable clinical screening and decision support.

Keywords:
biomarker-based predictionchronic kidney disease (CKD)explainable machine learning

Related Experiment Videos

Last Updated: Jul 16, 2026

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
09:16

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

Area of Science:

  • Nephrology
  • Artificial Intelligence
  • Machine Learning

Background:

  • Chronic kidney disease (CKD) is often diagnosed late, necessitating improved early detection methods.
  • Current screening tools lack the required discrimination and transparent operating thresholds for clinical deployment.

Purpose of the Study:

  • To develop and validate a robust, clinically deployable machine learning framework for early CKD detection.
  • To ensure the model provides high discrimination, an explicit operating threshold, and transparent explanations.

Main Methods:

  • A CKD detection framework integrating structured preprocessing, class imbalance handling, and 10-fold cross-validation with out-of-fold (OOF) prediction.
  • Clinically oriented threshold selection using the Youden index and explainability via SHAP and LIME.
  • Evaluation across two datasets using ten machine learning models, with a focus on gradient boosting methods.

Main Results:

  • LightGBM demonstrated superior clinical composite performance on both datasets, achieving near-ceiling OOF discrimination (ROC-AUC up to 99.98).
  • The model provided excellent sensitivity (e.g., 99.20%) and specificity (e.g., 99.60%) at optimal Youden thresholds, with robust cross-validation stability and strong calibration.
  • SHAP and LIME explanations confirmed alignment with clinically meaningful renal function and biomarker patterns.

Conclusions:

  • The proposed machine learning framework offers a reliable and explainable solution for CKD screening.
  • The model's performance and transparent decision-making support its translation into clinical workflows for improved patient outcomes.
  • Gradient boosting methods, specifically LightGBM, are highly effective for developing high-performance CKD detection models.